These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8221199)

  • 1. A phase II study of merbarone in patients with adenocarcinoma of the pancreas.
    Jones DV; Ajani JA; Winn RJ; Daugherty KR; Levin B; Krakoff IH
    Cancer Invest; 1993; 11(6):667-9. PubMed ID: 8221199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of merbarone in pancreatic carcinoma. A Southwest Oncology Group study.
    Kraut EH; Fleming T; Macdonald JS; Spiridonidis CH; Bradof JE; Baker LH
    Am J Clin Oncol; 1993 Aug; 16(4):327-8. PubMed ID: 8328410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I clinical and pharmacological study of merbarone.
    Dimaggio JJ; Warrell RP; Muindi J; Stevens YW; Lee SJ; Lowenthal DA; Haines I; Walsh TD; Baltzer L; Yaldaei S
    Cancer Res; 1990 Feb; 50(4):1151-5. PubMed ID: 2297763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II trial of merbarone in patients with malignant brain tumors.
    Malik UR; Dutcher JP; Caliendo G; Lasala P; Mitnick R; Wiernik PH
    Med Oncol; 1997; 14(3-4):159-62. PubMed ID: 9468039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results.
    Chang AY; Kim K; Glick J; Anderson T; Karp D; Johnson D
    J Natl Cancer Inst; 1993 Mar; 85(5):388-94. PubMed ID: 8094467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of merbarone (NSC 336628) in disseminated malignant melanoma. A Southwest Oncology Group study.
    Slavik M; Liu PY; Kraut EH; Natale RB; Flaherty LE; Sondak VK
    Invest New Drugs; 1995; 13(2):143-7. PubMed ID: 8617577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of merbarone in soft tissue sarcoma. A Southwest Oncology Group study.
    Kraut EH; Bendetti J; Balcerzak SP; Doroshow JH
    Invest New Drugs; 1992 Nov; 10(4):347-9. PubMed ID: 1487411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II evaluation of merbarone in renal cell carcinoma.
    Flanigan RC; Saiers JH; Wolf M; Kraut EH; Smith AY; Blumenstein B; Crawford ED
    Invest New Drugs; 1994; 12(2):147-9. PubMed ID: 7860233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of merbarone (NSC 336628) in patients with advanced gastric carcinoma.
    Ajani JA; Winn R; Baez L; Pollock T; Maher T; Hallinan-Fueger B; Newman J
    Cancer Invest; 1994; 12(5):488-90. PubMed ID: 7922705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatoma/merbarone. A Southwest Oncology Group study.
    Poplin EA; Tangen CM; Harvey WH; Macdonald JS
    Invest New Drugs; 1994; 12(4):337-40. PubMed ID: 7775137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of topotecan as a 21-day continuous infusion in patients with advanced or metastatic adenocarcinoma of the pancreas.
    Stevenson JP; Scher RM; Kosierowski R; Fox SC; Simmonds M; Yao KS; Green F; Broom C; Fields SZ; Krebs JB; O'Dwyer PJ
    Eur J Cancer; 1998 Aug; 34(9):1358-62. PubMed ID: 9849417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II evaluation of iproplatin in patients with advanced gastric and pancreatic cancer.
    Hubbard KP; Pazdur R; Ajani JA; Braud E; Blaustein A; King M; Llenado-Lee M; Winn R; Levin B; Abbruzzese JL
    Am J Clin Oncol; 1992 Dec; 15(6):524-7. PubMed ID: 1449117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of amonafide in advanced pancreatic adenocarcinoma.
    Linke K; Pazdur R; Abbruzzese JL; Ajani JA; Winn R; Bradof JE; Daugherty K; Levin B
    Invest New Drugs; 1991 Nov; 9(4):353-6. PubMed ID: 1804812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I trial of low dose N-phosphonacetyl-L-aspartic acid and high dose 5-fluorouracil administered concomitantly with radiation therapy for unresectable localized adenocarcinoma of the pancreas.
    Ardalan B; Ucar A; Reddy R; Livingstone AS; Markoe A; Schwade J; Richman SP; Donofrio K
    Cancer; 1994 Oct; 74(7):1869-73. PubMed ID: 8082092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of bisantrene administered by continuous 72-hour infusion for advanced pancreatic adenocarcinoma.
    Marschke RF; Kvols LK; Cullinan SA; Laurie JA; Mailliard JA; Tschetter LK; O'Connell MJ
    Med Pediatr Oncol; 1988; 16(4):269-70. PubMed ID: 3419393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of piroxantrone in metastatic gastric adenocarcinoma.
    Pazdur R; Bready B; Scalzo AJ; Brandof JE; Close DR; Kolbye S; Winn RJ
    Invest New Drugs; 1994; 12(3):263-5. PubMed ID: 7896547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of doxifluridine in advanced colorectal adenocarcinoma.
    Abele R; Alberto P; Kaplan S; Siegenthaler P; Hofmann V; Ryssel HJ; Hartmann D; Holdener EE; Cavalli F
    J Clin Oncol; 1983 Dec; 1(12):750-4. PubMed ID: 6230419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
    Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II trial of merbarone (NSC 336628) in the treatment of recurrent epithelial ovarian carcinoma. A Gynecologic Oncology Group Study.
    Look KY; Blessing JA; Adelson MD; Morris M; Bookman MA
    Am J Clin Oncol; 1996 Feb; 19(1):7-9. PubMed ID: 8554040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of didemnin B in advanced colorectal cancer.
    Jones DV; Ajani JA; Blackburn R; Daugherty K; Levin B; Patt YZ; Abbruzzese JL
    Invest New Drugs; 1992 Aug; 10(3):211-3. PubMed ID: 1428730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.